Table IV.

Individual toxicity grades according to grading criteria of the National Cancer Institute Common Toxicity Criteria (ver. 2).

	Groups [mean (95% confidence interval)]
Efficacy outcomes	Oncoxin (n=10)	Controls (n=5)	P-value
Leukocytes
Baseline	1.30 (0.95–1.65)	1.00	0.37
Visit 2	0.60 (0.23–0.97)	1.00	0.25
Visit 3	0.11 (−0.15–0.37)	0.80 (0.24–1.36)	0.04
Infections
Baseline	1.70 (1.35–2.05)	1.80 (1.24–2.36)	0.77
Visit 2	1.00 (0.66–1.34)	1.40 (0.29–2.51)	0.31
Visit 3	0.11 (−0.15–0.37)	1.20 (0.64–1.76)	<0.005
Alanine aminotransferase
Baseline	1.50 (0.99–2.01)	1.00	0.13
Visit 2	0.70 (0.22–1.18)	1.00	0.37
Visit 3	0.33 (−0.05–0.72)	1.00	0.04
Aspartate aminotransferase
Baseline	1.50 (0.99–2.01)	1.00	0.13
Visit 2	0.40 (0.03–0.77)	1.00	0.08
Visit 3	0.22 (−0.12–0.56)	1.00	0.012

Bold print indicates statistical significance.